Brief: Brain Presents New Strategy At Capital Markets Day

BRAIN Biotech AG

15/09/2020 15:09

Sept 15 (Reuters) - BRAIN BIOTECHNOLOGY RESEARCH AND
INFORMATION NETWORK AG  BNNn.DE :
    * PRESENTS NEW STRATEGY AT CAPITAL MARKETS DAY
    * PLANS TO DOUBLE REVENUES FROM BASE IN FISCAL YEAR '18/'19
AND
ACHIEVE AN EBITDA MARGIN OF 15% (+/-5%) OVER NEXT FOUR TO FIVE
YEARS
    * AIMS TO ACHIEVE A PROPORTION OF NEW PRODUCT SALES AROUND
30% OF
TOTAL REVENUES

Source text for Eikon:  ID:nNDL6Y2TRS 
Further company coverage:  BNNn.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;;))